One report assessed the expression amounts of genes encoding YAP, LATS1, LATS2, and TAZ in CML subjects at diverse phases of the disease that were resistant or sensitive to IM treatment and in healthy controls. The gene discussed is YAP1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.